| 殷子涵,吴胜智,胡骁栋,郑卫方.穴位埋线治疗慢传输型便秘的临床研究[J].浙江中西医结合杂志,2022,32(5): |
| 穴位埋线治疗慢传输型便秘的临床研究 |
| Clinical Study of Catgut Embedding Therapy for the Treatment of Slow Transit Constipation |
| 投稿时间：2021-05-23 修订日期：2022-03-23 |
| DOI： |
| 中文关键词: 穴位埋线 慢传输型便秘 |
| 英文关键词:catgut embedding therapy slow transit constipation |
| 基金项目: |
|
| 摘要点击次数: 343 |
| 全文下载次数: 6 |
| 中文摘要: |
| 目的 评估埋线治疗慢传输型便秘的安全性及有效性。方法 117例慢传输型便秘患者随机分成两组，实验组59例患者采用穴位埋线治疗，对照组58例患者采用口服乳果糖治疗，两组疗程均为4周，分析两组患者特征、并发症发生率、复发情况以及便秘水平。结果 两组患者在性别、年龄、病程方面没有统计学差异。实验组治疗前便秘评分显著高于治疗后（22.10±2.64 vs 13.25±3.53），（t=20.83，p＜0.01），对照组治疗前便秘评分显著高于治疗后（22.86±2.49 vs 16.17±4.28）（t=18.00，p＜0.01）。实验组与治疗组治疗前便秘评分没有显著差异（t=1.66，p＜0.11），治疗后实验组便秘评分显著低于对照组（t=4.02，p＜0.01）。对于治疗有效的患者，实验组随访（14.0±3.0）个月，复发率为11/52，对照组随访（14.4±3.2）个月，复发率18/37例，差异有统计学意义（2 =7.44, p＜0.01）。两组患者不良反应发生率分别为2/59和3/58，差异无统计学意义（2 =0.23, p=0.63）结论 穴位埋线治疗慢传输型便秘安全有效，值得在临床进一步推广运用。 |
| 英文摘要: |
| Objective To evaluate the safety and efficacy of catgut embedding therapy for the treatment of slow transit constipation (STC). Method 117 patients with STC confirmed by colonic transit study were randomly divided into two groups.Group 1 (59 patients), the experimental group, in which patients were treated with catgut embedding therapy for 4 weeks.Group 2(59 patients), the control group, in which patients were treated with lactulose for 4 weeks. Patient characteristics, complications, recurrence of STC, constipation state were evaluated. Results There was no obvious difference among the two groups in the age, gender and duration of this disease.The mean constipation score of the experimental group before and after treatment were (22.10±2.64) and (13.25±3.53) respectively (t=20.83，p＜0.01).The mean constipation score of the control group after treatment （16.17±4.28） was lower than in the control group before treatment(22.86±2.49)（t=18.00，p＜0.01）.No significant differences in mean constipation score was observed between the two groups before treatment. The mean constipation score after treatment in the experimental group (13.25±3.53) was significantly lower than in the control group(16.17±4.28) (t=4.02，p＜0.01).11 recurrent cases were observed in 52 patients who respond to treatment during (14.0±3.0) months follow-up in the experimental group, and 18/37 recurrent cases in the control group were observed during (14.4±3.2) months follow-up(2 =7.44, p＜0.01) . There is no significant differences in the complication rates was observed between the two groups(2/59 vs 3/58,2 =0.23, p=0.63）.Conclusion This research revealed that the catgut embedding therapy for STC is a safe and effective treatment with less complications and low recurrence rate, which is worthy of further popularization and application in clinical practice. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
